.Pharmacolibrary.Drugs.V_Various.V09F_Thyroid.V09FX04_SodiumIodide124i.SodiumIodide124i .Pharmacolibrary.Drugs.V_Various.V09F_Thyroid.V09FX04_SodiumIodide124i.SodiumIodide124i| name: | SodiumIodide124i |
| ATC code: | V09FX04 | route: | oral |
| n-compartments | 1 |
Sodium iodide (124I) is a radioactive iodine isotope used as a diagnostic radiopharmaceutical for positron emission tomography (PET) imaging, primarily to evaluate thyroid gland function, residual thyroid tissue, and metastases in thyroid carcinoma. It is not used therapeutically and serves as a tracer. Despite its diagnostic utility, 124I has not received widespread regulatory approval as standard of care due to its relatively limited availability and high cost compared to other iodine isotopes.
Pharmacokinetic parameters are reported in adult patients (both sexes) undergoing PET imaging for differentiated thyroid carcinoma. Parameters typically relate to healthy adults or patients post-thyroidectomy without severe renal or hepatic impairment.